GC-PRO Intervention

计划入组 994 人 · 首次发布于 2024 年 11 月 4 日

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

计划入组 65 人 · 首次发布于 2017 年 10 月 27 日

Oral OKT3 in Combination With Beta-D-Glucosylceramide

计划入组 20 人 · 首次发布于 2008 年 2 月 21 日

GC-3111A

GC-3111

GC-1112

GC CELL CORPORATION

South Korea

GC Biopharma Corp.

South Korea

GC Medical Equipment, Inc.

United States

Tetanus Clinical Trial Pipeline Shows Promise with 20+ Drugs in Development

GC Biopharma's Hunterase ICV Approved in Russia for Severe Hunter Syndrome

GC Biopharma Expands U.S. Plasma Collection Network with FDA Approval of Calexico Facility